Feedback / Questions
ART6043 - Artios Pharma
https://www.globenewswire.com/news-release/2026/05/26/3301040/0/en/Artios-Announces-First-Patient-Dosed-in-Randomized-Phase-2-POLKA-Study-Evaluating-DNA-Polymerase-Theta-Inhibitor-ART6043-in-gBRCA-mutated-HER2-Negative-Breast-Cancer.html
May 26, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next